A platform company
Linking pharmaceutical innovation and
commercialization with strong product
lifecycle management capability
commercialization with strong product
lifecycle management capability
Focusing on unmet clinical needs, we collaborate with global biotech/biopharma to jointly develop first- or best-in-class innovative products.
Adhering to the patient-centered philosophy, we are dedicated to providing competitive products and services that enable the more effective diagnosis and treatment, whilst enhancing clinical practice to the ultimate benefit of the patient.
Recently, Typhoon Doksuri has caused extreme rainfall in Beijing, Tianjin, Hebei, and other areas, leading to severe floods and geological disasters with casualties and significant property losses. China Medical System Holdings Ltd(“CMS”) quickly responded and made donation of RMB 1 million to the China Charity Federation on August 4th, to support emergency rescue and post-disaster reconstruction in severely affected areas of Beijing, Tianjin and Hebei, etc. At the same time, we pay the highest respects to all the heroes who are participating in the front-line disaster relief efforts! Let us unite and work together to tide over the difficulties. May the affected areas could be recovered as soon as possible.
We collaborate with global innovative companies in flexible structures to jointly build a pharmaceutical ecosystem in a sustainable and collaborative setting for the benefit of all stakeholders.
If you are interested in joining us, or curious about our business and products, please feel free to contact us.